Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVOID: Aliskiren in Type 2 Diabetes and Nephropathy
NCT00097955Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of aliskiren in diabetic nephropathy (DN), sponsored by Novartis. Started Oct 2004; status: completed.
02
Drugs
aliskiren
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00097955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097955.